Product Code: ETC8853996 | Publication Date: Sep 2024 | Updated Date: Jun 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Vagus nerve stimulation (VNS) is gaining traction in the Philippines for the treatment of refractory epilepsy and depression. As awareness of neuromodulation therapies increases, so does demand for implantable VNS devices. Despite high costs and limited local expertise, partnerships between global medtech firms and local providers are enhancing access.
Vagus nerve stimulation (VNS) is an emerging neuromodulation therapy for refractory epilepsy and treatment-resistant depression. The market is still nascent in the Philippines due to high device costs and the need for specialized implantation procedures. Uptake is currently limited to advanced neurology and psychiatric centers, but awareness is growing among neurologists and psychiatric practitioners.
Adoption of vagus nerve stimulation devices is challenged by their high cost, need for surgical implantation, and limited insurance coverage. Awareness among neurologists and psychiatrists is still growing, slowing prescription rates. Long-term data for efficacy in newer indications remains sparse in local clinical settings.
The increasing prevalence of epilepsy and treatment-resistant depression in the Philippines opens opportunities in the vagus nerve stimulation (VNS) market. Investors can explore partnerships with neurological clinics, introduce imported VNS devices, or establish distribution networks for implantable and external neuromodulation systems. Medical device registration support and physician training programs can create a competitive edge.
Medical devices for vagus nerve stimulation (VNS) therapy must be registered with the FDA under the medical device regulation framework, aligned with ASEAN Medical Device Directive (AMDD) standards. DOH policies support the introduction of novel neurological treatments, though reimbursement for VNS remains limited in public insurance schemes. Importers may seek special authorization for clinical use in hospitals.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Vagus Nerve Stimulation Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Vagus Nerve Stimulation Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Vagus Nerve Stimulation Market - Industry Life Cycle |
3.4 Philippines Vagus Nerve Stimulation Market - Porter's Five Forces |
3.5 Philippines Vagus Nerve Stimulation Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Philippines Vagus Nerve Stimulation Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Philippines Vagus Nerve Stimulation Market Revenues & Volume Share, By Biomaterial, 2021 & 2031F |
3.8 Philippines Vagus Nerve Stimulation Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Philippines Vagus Nerve Stimulation Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Vagus Nerve Stimulation Market Trends |
6 Philippines Vagus Nerve Stimulation Market, By Types |
6.1 Philippines Vagus Nerve Stimulation Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Philippines Vagus Nerve Stimulation Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Philippines Vagus Nerve Stimulation Market Revenues & Volume, By Implantable VNS Device, 2021- 2031F |
6.1.4 Philippines Vagus Nerve Stimulation Market Revenues & Volume, By External VNS Device, 2021- 2031F |
6.2 Philippines Vagus Nerve Stimulation Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Philippines Vagus Nerve Stimulation Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.2.3 Philippines Vagus Nerve Stimulation Market Revenues & Volume, By Depression, 2021- 2031F |
6.2.4 Philippines Vagus Nerve Stimulation Market Revenues & Volume, By Migraine, 2021- 2031F |
6.3 Philippines Vagus Nerve Stimulation Market, By Biomaterial |
6.3.1 Overview and Analysis |
6.3.2 Philippines Vagus Nerve Stimulation Market Revenues & Volume, By Metallic, 2021- 2031F |
6.3.3 Philippines Vagus Nerve Stimulation Market Revenues & Volume, By Ceramics, 2021- 2031F |
6.3.4 Philippines Vagus Nerve Stimulation Market Revenues & Volume, By Polymeric, 2021- 2031F |
6.4 Philippines Vagus Nerve Stimulation Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Philippines Vagus Nerve Stimulation Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Philippines Vagus Nerve Stimulation Market Revenues & Volume, By Neurology Clinics, 2021- 2031F |
6.4.4 Philippines Vagus Nerve Stimulation Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.4.5 Philippines Vagus Nerve Stimulation Market Revenues & Volume, By Research Centers, 2021- 2031F |
7 Philippines Vagus Nerve Stimulation Market Import-Export Trade Statistics |
7.1 Philippines Vagus Nerve Stimulation Market Export to Major Countries |
7.2 Philippines Vagus Nerve Stimulation Market Imports from Major Countries |
8 Philippines Vagus Nerve Stimulation Market Key Performance Indicators |
9 Philippines Vagus Nerve Stimulation Market - Opportunity Assessment |
9.1 Philippines Vagus Nerve Stimulation Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Philippines Vagus Nerve Stimulation Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Philippines Vagus Nerve Stimulation Market Opportunity Assessment, By Biomaterial, 2021 & 2031F |
9.4 Philippines Vagus Nerve Stimulation Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Philippines Vagus Nerve Stimulation Market - Competitive Landscape |
10.1 Philippines Vagus Nerve Stimulation Market Revenue Share, By Companies, 2024 |
10.2 Philippines Vagus Nerve Stimulation Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |